Skye Bioscience SKYE Balance Sheet (2012-2026)

NASDAQ SKYE
$1.07 -0.03 (-2.29%)
At close: Nov 16, 2026 · 4:00 PM EST
Reported Financials

Skye Bioscience Quarterly Balance Sheet

Periods 58 quarters
Latest Sep 2026

Skye Bioscience reported total assets of $0.01B and total liabilities of $0.00B for the quarter ended Sep 2026. This balance sheet covers 58 quarters of results from Apr 2012 through Sep 2026, standardized by Business Quant from the company’s SEC filings.

Balance SheetBalance Sheet Apr2012 Jul2012 Oct2012 Jan2013 Apr2013 Jul2013 Oct2013 Apr2014 Jun2014 Sep2014 Dec2014 Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026 Sep2026
Assets
Current Assets
Cash & EquivalentsCash & Equiv.
8.98M6.01M2.93M0.42M1.24M2.67M0.55M5.13M1.26M83.34M74.12M67.41M68.42M46.42M23.84M18.44M5.88M8.15M8.07M4.82M
Short-term InvestmentsInvestments (Current)
12.80M24.75M16.87M19.85M8.96M2.00M
Cash & Current Investments
8.98M6.01M2.93M0.42M1.24M2.67M0.55M5.13M1.26M83.34M74.12M67.41M68.42M59.22M48.59M35.31M25.74M17.11M10.06M4.82M
Receivables - NetNet Receivables
Receivables - OtherOther Receivables
0.01M0.05M0.05M0.05M0.05M0.05M
Receivables
0.05M
Prepaid Assets
0.55M0.82M0.87M0.71M0.78M0.96M0.27M0.21M0.19M0.64M1.10M0.66M0.20M0.58M1.26M3.71M0.50M1.22M0.42M0.21M
Current Assets
9.61M6.99M4.77M2.68M8.94M4.45M1.89M15.29M11.65M94.57M87.00M79.81M70.83M63.03M50.58M39.92M27.09M18.57M10.96M5.04M
Non-Current Assets
Property, Plant & Equipment (Net)PP&E (Net)
0.09M0.08M0.07M0.09M0.09M0.08M0.06M0.06M0.04M0.04M0.05M1.52M1.43M1.30M1.17M1.03M0.90M0.76M0.03M0.02M
Other Non-Current Assets
0.01M
Long-Term Investments
0.27M0.01M
Non-Current Assets
0.04M
Assets
5.07M
Liabilities
Current Liabilities
Accounts Payables
2.45M
Notes Payables
Payables
2.45M
Accumulated Expenses
0.13M
Other Accumulated Expenses
1.08M
Short term Debt
0.12M
Current Taxes
1.11M
Total Current Liabilities
3.71M
Non-Current Liabilities
Non-Current Debt
0.45M0.45M0.45M
Convertible Debt
1.68M1.84M2.01M
Preferred Stock Liabilities
Liabilities from Discontinued OperationsLiabilities from Discont. Ops
-0.03M
Operating Leases
0.08M0.06M0.03M0.01M0.08M0.21M0.19M0.17M0.15M0.13M0.11M0.27M0.22M0.17M0.12M0.08M
Other Non-Current Liabilities
0.06M0.02M0.01M326.000.10M
Total Non-Current Liabilities
3.93M4.22M5.26M9.76M12.02M14.07M
Total Liabilities
3.71M
Shareholder's Equity
Total Debt
0.12M
Common Equity
1.36M
Liabilities and Shareholders Equity
5.07M
Retained Earnings
-210.10M
Preferred Shares
Treasury Shares
5,000.00M

Skye Bioscience Balance Sheet API

Pull Skye Bioscience's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=SKYE&statement=BS&frequency=Quarter&period=all&api_key=YOUR_API_KEY